ImmunoGen (IMGN) earnings: expect -50% revenue decline

1:17 pm ET, 02 May 2019

ImmunoGen, Inc. (IMGN) is announcing earnings on May 03, before market opening. Wondering what revenue and earnings will look like?

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $10M, which implies -50% growth rate year-over-year.

Earnings per share are expected to come in at $-0.31. If this materializes, EPS will decline -3% year-over-year.

How did the stock do last month?

Over the last month, ImmunoGen, Inc. (IMGN) returned -2.7%.

What do analysts say about the stock?

ImmunoGen, Inc. (IMGN) average analyst price target is 90.79% above its current price ($2.39).

For the latest price and information on ImmunoGen, Inc., please visit Finstead and ask for "IMGN", "IMGN analysis" or "IMGN news".

ImmunoGen, Inc. (IMGN) Stock Guide

Updated at: 1:18 am ET, 18 Sep 2020

Before we start: if you're looking for IMGN stock price, you can quickly find it out by visiting Finny and typing "IMGN quote". If you're looking for a quick scoop on IMGN stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "IMGN". You'll get all this info in one place. Or you can just type "IMGN news" to get the latest stock news.

Looking to buy or sell ImmunoGen, Inc. (IMGN)? Interested in getting the full scoop on IMGN, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this IMGN stock guide, we'll address key questions about IMGN, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are IMGN earnings?
2. What is IMGN stock forecast (i.e., prediction)?
3. IMGN buy or sell? What is IMGN Finny Score?
4. What are the reasons to buy IMGN? Why should I buy IMGN stock?
5. What are the reasons to sell IMGN? Why should I sell IMGN stock?
6. What are IMGN key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are IMGN earnings?

IMGN trailing 12-month earnings per share (EPS) is -$0.44.

Analyst Predictions

2. What is IMGN stock forecast (i.e., prediction)?

Based on IMGN analyst price targets, IMGN stock forecast is $6.96 (for a year from now). That means the average analyst price target for IMGN stock is $6.96. The prediction is based on 9 analyst estimates.

The low price target for IMGN is $4.00, while the high price target is $12.00.

IMGN analyst rating is Buy.

Analysis

3. IMGN buy or sell? What is IMGN Finny Score?

#{finnyScore:63}Our quantitative analysis shows 5 reasons to buy and 3 reasons to sell IMGN, resulting in Finny Score of 63.

4. What are the reasons to buy IMGN? Why should I buy IMGN stock?

Here are the reasons to buy IMGN stock:

5. What are the reasons to sell IMGN? Why should I sell IMGN stock?

Let's look at the reasons to sell IMGN stock (i.e., the bear case):

  • IMGN quarterly revenue growth was -3.30%, lower than the industry and sector average revenue growth (0.28% and 0.83%, respectively). See IMGN revenue growth chart.
  • IMGN short share of float is 11.34%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See IMGN short share of float chart.
  • IMGN short interest (days to cover the shorts) ratio is 8.59. The stock garners more short interest than the average industry, sector or S&P 500 stock. See IMGN short interest ratio chart.

Key Stats

6. What are IMGN key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for IMGN:

Metrics IMGN
Price $3.67
Average Price Target / Upside $6.96 / 89.39%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 296
Market Cap $652.79M
Forward P/E Ratio -4.99
Price/Book Ratio 7.55
Revenue (TTM) $86.46M
YoY Quarterly Revenue Growth -3.30%
Profit Margin -81.34%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us